Days of steady US pricing for pharma players to come in FY24, says JM Financial

Not just pharma companies, JM Financial also sees a bright future for diagnostics as well as hospital players in FY24

Related Keywords

Sun Pharma ,Biocon ,Global Health ,Nuvama Institutional Equities ,Ipca Labs ,Average Revenue Per Occupied Bed ,Pharma ,Drugmaker ,Pharma Sector ,Iagnostics ,Hospitals ,Healthcare Services ,Pharma And Healthcare ,